SCHEMBL21058417

SCHEMBL21058417

C=COCCCOS(=O)(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FNTA P49354 2/20 0.36
FNTB P49356 2/20 0.36
ALDH1A1 P00352 2/20 0.31
TSHR P16473 2/20 0.31
CYP3A4 P08684 1/20 0.31
CA2 P00918 8/20 0.31
CA9 Q16790 8/20 0.31
CA1 P00915 7/20 0.31
KDM4E B2RXH2 1/20 0.31
USP2 O75604 1/20 0.31
LMNA P02545 1/20 0.31
MMP9 P14780 1/20 0.31
ALOX15 P16050 1/20 0.31
CA12 O43570 2/20 0.30
CA3 P07451 2/20 0.30
CA4 P22748 2/20 0.30
CA6 P23280 2/20 0.30
CA5A P35218 2/20 0.30
CA7 P43166 2/20 0.30
CA14 Q9ULX7 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15071412 0.86 CA2 (0.32) FNTAFNTBCA2CA9
SCHEMBL923333 0.81 FNTA (0.45) FNTAFNTBALDH1A1TSHRCA2
SCHEMBL1118647 0.78 USP2 (0.58) ALDH1A1TSHRCA2CA9CA1
SCHEMBL17456557 0.78 FNTA (0.44) FNTAFNTBALDH1A1TSHRCA2
SCHEMBL786527 0.76 CA2 (0.45) FNTAFNTBALDH1A1TSHRCYP3A4
SCHEMBL730023 0.76 APP (0.41) LMNA
SCHEMBL3640927 0.75 CA2 (0.50) FNTAFNTBALDH1A1TSHRCA2
SCHEMBL600088 0.75
SCHEMBL5969694 0.75 TSHR (0.63) FNTAFNTBALDH1A1TSHRCYP3A4
SCHEMBL4754921 0.75 FNTA (0.43) FNTAFNTBALDH1A1TSHRCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109641994-B Hydrophilic copolymer and medical device 泰尔茂株式会社 2021-07-09 CN claimed
US-12582752-B2 Medical device and method for manufacturing same TERUMO KABUSHIKI KAISHA (JP) 2026-03-24 US disclosed
US-12054564-B2 Medical device and method for manufacturing same TERUMO KABUSHIKI KAISHA (JP) 2024-08-06 US disclosed
EP-4005794-B1 MEDICAL INSTRUMENT AND METHOD FOR MANUFACTURING SAME TERUMO CORP (JP) 2024-07-10 EP disclosed
EP-3747479-B1 MEDICAL INSTRUMENT TERUMO CORP (JP) 2024-05-29 EP disclosed
US-11872326-B2 Medical instrument TERUMO KABUSHIKI KAISHA (JP) 2024-01-16 US disclosed
CN-114269400-B Medical device and method for manufacturing the same 泰尔茂株式会社 2023-12-19 CN disclosed
CN-114269399-B Medical device and method for manufacturing the same 泰尔茂株式会社 2023-09-19 CN disclosed
CN-114269401-B Medical device and method for manufacturing the same 泰尔茂株式会社 2023-07-04 CN disclosed
CN-114269402-B Medical device and method for manufacturing the same 泰尔茂株式会社 2023-06-09 CN disclosed
WO-2021033765-A1 MEDICAL INSTRUMENT AND METHOD FOR MANUFACTURING SAME テルモ株式会社 2021-02-25 WO disclosed
WO-2021033764-A1 MEDICAL INSTRUMENT AND PRODUCTION METHOD THEREFOR テルモ株式会社 2021-02-25 WO disclosed
WO-2021033769-A1 MEDICAL INSTRUMENT AND METHOD FOR MANUFACTURING SAME テルモ株式会社 2021-02-25 WO disclosed
CN-112368309-A Hydrophilic copolymer and medical device 泰尔茂株式会社 2021-02-12 CN disclosed
EP-3747479-A1 MEDICAL INSTRUMENT Terumo Kabushiki Kaisha (JP) 2020-12-09 EP disclosed
US-20200376171-A1 MEDICAL INSTRUMENT TERUMO KABUSHIKI KAISHA (JP) 2020-12-03 US disclosed
CN-111565768-A Medical instrument 泰尔茂株式会社 2020-08-21 CN disclosed
WO-2019163764-A1 MEDICAL INSTRUMENT テルモ株式会社 2019-08-29 WO disclosed
EP-3505543-A1 HYDROPHILIC COPOLYMER AND MEDICAL DEVICE Terumo Kabushiki Kaisha (JP) 2019-07-03 EP disclosed
US-20190185776-A1 HYDROPHILIC COPOLYMER AND MEDICAL DEVICE TERUMO KABUSHIKI KAISHA (JP) 2019-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12582752-B2 Medical device and method for manufacturing same STS, DEGS1, HPSE FNTA 3953/4885FNTB 3990/4885ALDH1A1 790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.